Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article
SELBYVILLE, Del., April 19, 2021 /PRNewswire/ According to latest report Clinical Trial Market by Phases (Phase I, Phase II, Phase III, Phase IV), Study Design (Interventional Study, Observational Study, Expanded Access Study), Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027 , by Global Market Insights Inc., the market valuation of clinical trials will cross $59.6 billion by 2027.
Major clinical trial market players include Laboratory Corporation of America Holdings, IQVIA, Pharmaceutical Product Development and PRA Health Science, PAREXEL International.
Growing R&D expenditure and increasing number of drugs in various phases is anticipated to significantly boost the market growth. Pharmaceutical and biopharmaceutical industry has one of the highest R&D expenses worldwide. Therefore, this will encourage various biopharma &
Clinical Trial Market Revenue to Cross USD 59 6 Bn by 2027: Global Market Insights Inc prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.